130 related articles for article (PubMed ID: 9440622)
1. Fas antigen expression of hepatocytes and its modification by immunosuppressants.
Yokoyama I; Hayakawa A; Hayashi S; Kobayashi T; Negita M; Takagi H
Dig Dis Sci; 1997 Dec; 42(12):2471-5. PubMed ID: 9440622
[TBL] [Abstract][Full Text] [Related]
2. Decreased Fas antigen expression of cultured hepatocytes with FK 506.
Yokoyama I; Hayakawa A; Hayashi S; Kobayashi T; Negita M; Katayama A; Namii Y; Nagasaka T; Kojima T; Koike C; Uchida K; Takagi H
Transplant Proc; 1996 Dec; 28(6):3189-90. PubMed ID: 8962237
[No Abstract] [Full Text] [Related]
3. Activation-induced cell death in murine T cell hybridomas. Differential regulation of Fas (CD95) versus Fas ligand expression by cyclosporin A and FK506.
Brunner T; Yoo NJ; LaFace D; Ware CF; Green DR
Int Immunol; 1996 Jul; 8(7):1017-26. PubMed ID: 8757947
[TBL] [Abstract][Full Text] [Related]
4. Fas antigen expression and apoptosis induction of in vitro cultured hepatocytes with high concentrations of cyclosporine A.
Yokoyama I; Hayakawa A; Hayashi S; Kobayashi T; Negita M; Katayama A; Nagasaka R; Namii Y; Kojima T; Koike C; Uchida K; Takagi H
Transplant Proc; 1996 Jun; 28(3):1383-4. PubMed ID: 8658705
[No Abstract] [Full Text] [Related]
5. The protective effect of cyclosporine A on anti-Fas antibody-induced hepatitis in mice.
Okamoto T; Hitomi Y; Hara A
Jpn J Pharmacol; 1999 Apr; 79(4):485-8. PubMed ID: 10361889
[TBL] [Abstract][Full Text] [Related]
6. In vivo analysis of Fas antigen-mediated apoptosis: effects of agonistic anti-mouse Fas mAb on thymus, spleen and liver.
Nishimura Y; Hirabayashi Y; Matsuzaki Y; Musette P; Ishii A; Nakauchi H; Inoue T; Yonehara S
Int Immunol; 1997 Feb; 9(2):307-16. PubMed ID: 9040012
[TBL] [Abstract][Full Text] [Related]
7. Comparative evaluation of in vitro and in vivo immunosuppressive potential of cyclosporin G with cyclosporin A and FK-506.
Saada V; Pham-Huy C; Voisin J; Righenzi S; Rucay P; Claude JR; Duc HT
Int J Immunopharmacol; 1996 Jan; 18(1):79-87. PubMed ID: 8732436
[TBL] [Abstract][Full Text] [Related]
8. Unexpected up-regulation of gene expression by cyclosporin A and FK-506 in a T-cell lymphoma: both immunosuppressants augment Ly-6E antigen induction by interferon-gamma in the presence of ionomycin.
Altmeyer A; Staruch MJ; Fischer PA; Durette PL; Tocci MJ; Sigal NH; Dumont FJ
Int J Immunopharmacol; 1991; 13(8):1187-99. PubMed ID: 1726093
[TBL] [Abstract][Full Text] [Related]
9. Islet cell damage associated with tacrolimus and cyclosporine: morphological features in pancreas allograft biopsies and clinical correlation.
Drachenberg CB; Klassen DK; Weir MR; Wiland A; Fink JC; Bartlett ST; Cangro CB; Blahut S; Papadimitriou JC
Transplantation; 1999 Aug; 68(3):396-402. PubMed ID: 10459544
[TBL] [Abstract][Full Text] [Related]
10. Effect of cyclosporine and tacrolimus on the growth of Epstein-Barr virus-transformed B-cell lines.
Beatty PR; Krams SM; Esquivel CO; Martinez OM
Transplantation; 1998 May; 65(9):1248-55. PubMed ID: 9603175
[TBL] [Abstract][Full Text] [Related]
11. Fas system and apoptosis in viral hepatitis.
Hayashi N; Mita E
J Gastroenterol Hepatol; 1997 Oct; 12(9-10):S223-6. PubMed ID: 9407341
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of the immunosuppressive macrolides FK-506 and rapamycin on activation-induced T-cell apoptosis.
Staruch MJ; Sigal NH; Dumont FJ
Int J Immunopharmacol; 1991; 13(6):677-85. PubMed ID: 1721613
[TBL] [Abstract][Full Text] [Related]
13. Immunosensitization of melanoma tumor cells to non-MHC Fas-mediated killing by MART-1-specific CTL cultures.
Frost PJ; Butterfield LH; Dissette VB; Economou JS; Bonavida B
J Immunol; 2001 Mar; 166(5):3564-73. PubMed ID: 11207317
[TBL] [Abstract][Full Text] [Related]
14. The inhibition of T-cell-receptor-induced Fas ligand upregulation by cyclosporine and FK 506.
Nakajima H; Oka T
Transplant Proc; 1996 Apr; 28(2):1052-5. PubMed ID: 8623224
[No Abstract] [Full Text] [Related]
15. 2-Chlorodeoxyadenosine: lack of synergism with cyclosporine A and tacrolimus (FK 506).
Nowaczyk M; Stephień-Sopniewska B; Korczak-Kowalska G; Mrowiec T; Górski A
Arch Immunol Ther Exp (Warsz); 1995; 43(5-6):329-32. PubMed ID: 8744655
[TBL] [Abstract][Full Text] [Related]
16. The immunosuppressant drug FK506 prevents Fas-induced apoptosis in human hepatocytes.
Gómez-Lechón MJ; Serralta A; Donato MT; Jiménez N; O'connor E; Castell JV; Mir J
Biochem Pharmacol; 2004 Dec; 68(12):2427-33. PubMed ID: 15548389
[TBL] [Abstract][Full Text] [Related]
17. Immunophilins may limit calcineurin inhibition by cyclosporine and tacrolimus at high drug concentrations.
Kung L; Halloran PF
Transplantation; 2000 Jul; 70(2):327-35. PubMed ID: 10933159
[TBL] [Abstract][Full Text] [Related]
18. ECH, an epoxycyclohexenone derivative that specifically inhibits Fas ligand-dependent apoptosis in CTL-mediated cytotoxicity.
Mitsui T; Miyake Y; Kakeya H; Osada H; Kataoka T
J Immunol; 2004 Mar; 172(6):3428-36. PubMed ID: 15004142
[TBL] [Abstract][Full Text] [Related]
19. Effects of Cyclosporine, Tacrolimus, and Rapamycin on Osteoblasts.
Martín-Fernández M; Rubert M; Montero M; de la Piedra C
Transplant Proc; 2017 Nov; 49(9):2219-2224. PubMed ID: 29149986
[TBL] [Abstract][Full Text] [Related]
20. Cell death mediated by alloreactive cytotoxic T cells via the granule exocytosis or the Fas pathway is independent of p34cdc2 kinase: Fas dependent killing of cells arrested in the cell cycle.
Waring P; Müllbacher A
Immunol Cell Biol; 2001 Jun; 79(3):264-73. PubMed ID: 11380680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
